
Ipca Laboratories Q2 FY27 Results: Consolidated Net Profit ₹389 Crore on Total Income of ₹2,935 Crore
Ipca Laboratories (NSE: IPCALAB) said in a filing on 5 Nov 2026 that consolidated total income for the quarter ended 30 Sept 2026 was ₹2,934.97 crore and net profit was ₹389.32 crore. Standalone total income was ₹2,274.53 crore and standalone net profit was ₹387.29 crore.
- Earnings
- Pharmaceuticals